1. Home
  2. HYPR vs ALDX Comparison

HYPR vs ALDX Comparison

Compare HYPR & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

HOLD

Current Price

$1.11

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$2.08

Market Cap

136.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYPR
ALDX
Founded
2014
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.8M
136.9M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
HYPR
ALDX
Price
$1.11
$2.08
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$1.59
$5.50
AVG Volume (30 Days)
1.6M
1.9M
Earning Date
05-12-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
23.21
40.43
EPS
N/A
N/A
Revenue
$13,563,000.00
N/A
Revenue This Year
$50.75
N/A
Revenue Next Year
$29.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.22
N/A
52 Week Low
$0.76
$1.07
52 Week High
$2.22
$6.18

Technical Indicators

Market Signals
Indicator
HYPR
ALDX
Relative Strength Index (RSI) 33.21 54.51
Support Level $0.95 $1.49
Resistance Level $1.17 $2.27
Average True Range (ATR) 0.14 0.20
MACD -0.03 0.02
Stochastic Oscillator 5.69 44.51

Price Performance

Historical Comparison
HYPR
ALDX

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: